Comprehensive India Pharma Market Report Launching at CPhI India 2014

AMSTERDAM, November 13, 2014 /PRNewswire/ --

Report to analyse trends from leading Indian pharma players and forecast new markets and growth areas in a region predicted by analysts to reach US$45 billion by 2020  

CPhI India, organised by UBM Live, announces that it will be releasing a comprehensive India pharma market report at CPhI India 2014 (2-4^th December 2014 in Mumbai). The report, conducted with the help of research partner Global Business Reports, will include thought-provoking analysis from key industry players - e.g. Cipla, Piramal, Sun, Lupin, Aurobindo and Biocon, Government bodies (IBEF/Pharmexcil) and explore new growth areas emerging across the country.

     (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

Now the tenth largest economy in the world and with global exports of around US$15 billion over the last 12 months^[i], India is an innovation hub and a well-known focal point of the pharmaceutical industry and Mckinsey and Company forecast a staggering total value of US$45bn by 2020^[ii]. Around 220 countries are sourcing pharma products from India, with the top 20 of India's pharmaceutical companies contributing to almost two-thirds of the country's total exports.

Those companies are further expected to increase capital expenditure (capex) by 40 per cent to over US$8.3 billion by 2017-18^[iii]. India is constantly looking to increasingly match high quality Western standards, whilst maintaining lower manufacturing costs, showcasing the Indian pharma markets unique position and providing an optimum investment platform for international companies.

The CPhI India report will feature a robust analysis of the Indian pharma market and includes significant contributions from over 98 companies and all major Indian manufacturers, evaluating conditions for both foreign and domestic companies. Printed copies of the detailed 100+ page report will be available at CPhI India along with a media-ready version produced and launched to media at the event - including an overview of trends contained within the full report.

CPhI India will take place at the Bombay Convention and Exhibition Centre, Mumbai (India) from the 2^nd to the 4^th of December 2014 and is expected to be attended by nearly 30,000 industry executives from over 95 countries. CPhI will co-locate with P-MEC India, ICSE India and BioPh as all sectors of the pharma industry attend this huge event. This key global event is the perfect meeting place to network, observe trends and enhance new business opportunities. A series of technical seminars will take place throughout the show, providing detailed insights into current trends, issues and developments surrounding the pharma community, alongside the CPhI Pharma Awards India. A mobile app will be available to assist with navigation throughout CPhI India and provide easier access to all areas of the event.

Another new initiative is the introduction of the CPhI Global Angels charity campaign, which was first launched earlier this year at CPhI Worldwide. It is being rolled out across CPhI's global portfolio and is designed to call on the pharma community to lend its support to this global charity that is transforming disadvantaged communities around the world.

It's a really exciting time to be working across this leading pharma market as the global demand for Indian made drugs continues to rise- particularly with Western economies looking to further expand their use of generics. Meet the movers and shakers in India's pharma machinery, technology, ingredients, outsourcing and bio-pharma industry for a competitive advantage that will help grow your business.

"With the highest number of USFDA approved facilities outside of the US, it is unsurprising that India has seen a huge growth in the number of exports. India's economy is thriving as the demand for generics is on the rise and companies are looking to drive down manufacturing costs. India is well positioned to accommodate increased demand, providing expertise in development and manufacturing. This is an amazing time for the CPhI community to gather in Mumbaiduring the CPhI India,a world class pharma event that continues to provide an essential platform for international and domestic suppliers&buyers to break into the market. There has never been a better time to invest in such a dynamic and thriving economy and we look forward to another successful CPhI India." Chris Kilbee, Group Director Pharma at UBM Live.

For more information about the show or to register please visit http://www.cphi.com/india/home

Notes to editors  

About CPhI 

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, Southeast Asia, Istanbul, Russia and South America and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com.

For more information visit: http://www.cphi.com

The UBM Live annual schedule of Pharmaceutical events includes; CPhI, ICSE Korea (2-3 September, 2014 at the COEX- Seoul, South Korea); CPhI, ICSE, P-MEC and InnoPack Worldwide (7-9 October 2014, Paris Nord Villepinte- France); CPhI and P-MEC India (2-4 December, 2014 at the Bombay Exhibition Centre- Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (22-24 April, 2015 at the Big Sight Exhibition Centre- Tokyo). CPhI Russia and IPhEB (27-29 April, 2015 at the VVC, Pavilion Nr 75, Moscow Russia); CPhI, P-MEC and Innopack South East Asia (26-28 May, 2015 at the Jakarta International Expo- Jakarta, Indonesia); CPhI Istanbul (3-5 June, 2015, at the Lutfi Kirdar Convention and Exhibition Centre- Turkey); CPhI, Hi and Fi, ICSE, P-MEC, BioPh and LabWorld China (24-26 June, 2015 at SNIEC- Shanghai, China); CPhI South America August 2014 at Expo Centre Norte, Sao Paulo- Brazil; CPhI, ICSE Korea (7-9 September, 2015 at the COEX- Seoul, South Korea); CPhI, ICSE, P-MEC and InnoPack Worldwide (13-15 October 2015, IFEMA- Feria de Madrid, Spain)

About UBM Live 

UBM Live connects people and creates opportunities for companies across five continents to develop new business, meet customers, launch new products, promote their brands, and expand their market. Through premier brands such as TFM&A, Internet World, IFSEC, MD&M, CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM Live exhibitions, conferences, awards programs, publications, Websites, and training and certification programs are an integral part of the marketing plans of companies across more than 20 industry sectors.

For media enquiries, please contact: Alex Heeley or Tristan Jervis, De Facto Communications, T: +44-207-203-6745 / 6740, E: [email protected] / [email protected]

i. http://www.process-worldwide.com/management/markets_industries/articles/459623

ii. http://gbreports.com/2014/10/04/can-india-become-pharmacy-world/

iii. http://www.pharmaasia.com/article/india-pharma-eyes-export-expansion-in-latin-america/10859

SOURCE UBM Live